NASDAQ - AMZN +15% gap pre-marketben.. 52-week-high-on... megduplázta a profitját..
BDSI - +46% gap ....
"BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced today statistically significant results with BEMA(TM) Fentanyl in cancer patients with breakthrough pain in its pivotal Phase III efficacy clinical trial for the product. The results are based on achievement of the primary efficacy endpoint of the trial, Summary of Pain Intensity Difference (SPID), compared to placebo. "
"(RTTNews) - Telik Says Triplet Combination Was Generally Well-tolerated At All TELCYTA Doses Evaluated, With Toxicities Similar To Those Expected With Each Drug Alone "